Veloxis Pharmaceuticals A/S, of Copenhagen, said its capital has been increased by 1 million new shares with a nominal value of DKK0.10 (US1.4 cents) each corresponding to nominally DKK100,000 as a consequence of the exercise of warrants by former employees of the company granted under the warrant program. Proceeds to the company will amount to DKK350,000 (US$50,167).